Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/24376
Title: | Fracture risk reduction with use of dipeptidyl peptidase-4 inhibitors: is there immortal time bias? | Authors: | Driessen, J. H. M. Knapen, L. M. GEUSENS, Piet VAN DEN BERGH, Joop |
Issue Date: | 2017 | Publisher: | SPRINGER LONDON LTD | Source: | OSTEOPOROSIS INTERNATIONAL, 28(8), p. 2429-2430 | Notes: | [Driessen, J. H. M.; Knapen, L. M.] Maastricht Univ, CAPHRI Sch Publ Hlth & Primary Care, Maastricht, Netherlands. [Driessen, J. H. M.; van den Bergh, J. P. W.] Maastricht Univ, NUTRIM Sch Nutr & Translat Res Metab, Maastricht, Netherlands. [Driessen, J. H. M.; Knapen, L. M.] Maastricht Univ, Med Ctr, Dept Clin Pharm & Toxicol, Maastricht, Netherlands. [Driessen, J. H. M.] Utrecht Inst Pharmaceut Sci, Div Pharmacoepidemiol & Clin Pharmacol, Utrecht, Netherlands. [Geusens, P. P. M. M.; van den Bergh, J. P. W.] Hasselt Univ, Biomed Res Ctr, Agoralaan Gebouw D, B-3590 Diepenbeek, Belgium. [Geusens, P. P. M. M.; van den Bergh, J. P. W.] Maastricht Univ, Med Ctr, Dept Internal Med, Subdivis Rheumatol,CAPHRI, Maastricht, Netherlands. [van den Bergh, J. P. W.] VieCuri Med Ctr, Dept Internal Med, POB 1926, NL-5900 BX Venlo, Netherlands. | Document URI: | http://hdl.handle.net/1942/24376 | ISSN: | 0937-941X | e-ISSN: | 1433-2965 | DOI: | 10.1007/s00198-017-4120-2 | ISI #: | 000406275400020 | Rights: | © International Osteoporosis Foundation and National Osteoporosis Foundation 201 | Category: | A1 | Type: | Journal Contribution | Validations: | ecoom 2018 |
Appears in Collections: | Research publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
o.pdf Restricted Access | Published version | 276.51 kB | Adobe PDF | View/Open Request a copy |
SCOPUSTM
Citations
3
checked on Sep 3, 2020
WEB OF SCIENCETM
Citations
3
checked on Oct 14, 2024
Page view(s)
60
checked on Sep 5, 2022
Download(s)
42
checked on Sep 5, 2022
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.